JCAD | The Journal of Clinical and Aesthetic Dermatology
Menu
© 2020 JCAD | The Journal of Clinical and Aesthetic Dermatology. All rights reserved.
Menu
by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research, Las Vegas, Nevada and at Henderson Dermatology Research in Henderson, Nevada; is Adjunct Clinical Professor (Dermatology) at ableouro University Nevada, Las Vegas, Nevada; and practices Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. J
aJames Q. Del Rosso, DO, FAOCD, FAAD; bEmil A. Tanghetti, MD; cHilary E. Baldwin, MD; dDavid A. Rodriguez, MD; eIlia L. Ferrusi, PhD aJDR Dermatology Research/Thomas Dermatology, Las Vegas, Nevada bThe Center for Dermatology and Laser Surgery, Sacramento, California cThe Acne Treatment and Research Center, Morristown, New Jersey dDermatology Associates and Research, Coral Gables, Florida;
by David A. Jones, MD, PhD Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts Abstract Rosacea is a common skin condition thought to be primarily an inflammatory disorder. Neutrophils, in particular, have been implicated in the inflammation associated with rosacea and mediate many of their effects through the release of reactive oxygen species. Recently,
by Jonette E. Keri, MD, PhD, and Adena E. Rosenblatt Department of Dermatology, University of Miami Miller School of Medicine, Miami, Florida Disclosure: The authors identified no conflicts of interest.
by Amy Forman Taub, MD, Assistant Clinical Professor of Dermatology, Northwestern University Medical School, Chicago, Illinois; Founder/Director of Advanced Dermatology, Skinfo, SkinQRI, Lincolnshire, Illinois Erin C. DeVita, CST, CMSLO, CCRC, Advanced Dermatology, SkinQRI, Lincolnshire, Illinois Abstract Introduction: Many laser and light devices have reported to be successful in the treatment of the flushing, background erythema,